Drawing for CELLFORGE

USPTO serial 99734085

CELLFORGE

Reviewed by CopyMark Law Group

Status 661
Filing date
Status date
Registration date
—
Examiner
LAW, CHRISTOPHER M
Law office
TMEG LAW OFFICE 103

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CELLFORGE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jeffrey P. Dunning

Jeffrey P. Dunning Greenberg Traurig, LLP360 North Green StreetSuite 1300Chicago, IL 60607

Goods and services

ClassDescriptionStatusFirst use
001Biological tissue, namely, cells, organoids and tissue models for use in scientific and medical researchACTIVE—
009Downloadable artificial intelligence powered software for cell therapy manufacturing, human tissue design, analyzing cellular state data, generating digital cell atlases, discovering and optimizing cell culture protocols, predicting cell differentiation outcomes, optimizing biomanufacturing workflows, collecting high-resolution cell telemetry data, and generating digital cell state references; electronic multi-purpose cell culture device for processing organoids, stem cells, and primary cells for scientific and research use; computer hardware and recorded software systems for use in drug discovery, drug development, isolation and cultivation of human tissues and cells, cell therapy manufacturing and human tissue designACTIVE—
040Custom manufacturing of cells, organoids and tissue models for use in scientific and medical researchACTIVE—
042Platform as a service (PAAS) featuring software platforms for cell therapy manufacturing, human tissue design, analyzing cellular state data, generating digital cell atlases, discovering and optimizing cell culture protocols, predicting cell differentiation outcomes, optimizing biomanufacturing workflows, collecting high-resolution cell telemetry data, and generating digital cell state references; Software as a service (SaaS) featuring machine learning and reinforcement learning software for closed-loop control of biomanufacturing systems; Providing temporary use of non-downloadable cloud-based software for integrating laboratory instruments and automating cell therapy production workflows; scientific research in the fields of drug discovery, drug development, isolation and cultivation of human tissues and cells, cell therapy manufacturing and human tissue design; Scientific laboratory services, namely, tissue characterization in the nature of analyzing biological tissue properties using imaging processes; Software as a service (SaaS) featuring non-downloadable software for software orchestration in the field of cell therapy manufacturing technology; scientific laboratory services relating to the isolation and cultivation of human tissues and cells; engineering services in the field of human tissue design and tissue engineeringACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 25, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 25, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 25, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 10, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 10, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 10, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 10, 2026DOCKASSIGNED TO EXAMINER—
Jul 29, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 30, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 30, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance